Psychiatry and Neurology, Neurology · Greensboro, NC
NPI
1154380798
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
301 E Wendover Ave
Greensboro, NC, 27401
Phone (336) 547-1790
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
9,110 services
Medicare patients, 2024
219
Average age 77
Drug cost, 2024
$753K
3,270 prescriptions
Company payments, 2025
$799
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca S Tat was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 242 times for 149 patients. In total Rebecca S Tat billed 9,110 services in 31 codes, and Medicare paid $80K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 242 | 149 | $11.63 | $2,815 |
| 99214 Office E&M - Established | Office | 129 | 111 | $83.37 | $11K |
| 99213 Office E&M - Established | Office | 101 | 89 | $52.65 | $5,317 |
| 99215 Office E&M - Established | Office | 86 | 66 | $125.04 | $11K |
| 99205 Office E&M - New | Office | 36 | 36 | $144.35 | $5,197 |
| 99204 Office E&M - New | Office | 14 | 14 | $90.04 | $1,261 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 14 | 13 | $24.28 | $340 |
By year: 2022 $86K for 7,815 services; 2023 $79K for 9,474 services; 2024 $80K for 9,110 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 24 | 23 | $8.40 | $202 |
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca S Tat prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,186 prescriptions and refills. In total Rebecca S Tat wrote 3,270 Medicare prescriptions that cost $753K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,186 | 3,138 | 323 | $45K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 463 | 1,237 | 151 | $24K |
| Primidone Generic | 280 | 787 | 80 | $11K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 191 | 508 | 48 | $5,618 |
| Clonazepam Generic | 124 | 221 | 29 | $576 |
| Escitalopram Oxalate Generic | 88 | 256 | 25 | $1,211 |
| Amantadine Amantadine Hcl | 72 | 182 | 26 | $4,270 |
| Ropinirole Hcl Generic | 65 | 179 | 19 | $2,302 |
| Propranolol Hcl Generic | 63 | 179 | 19 | $1,030 |
| Rytary Carbidopa/Levodopa | 59 | 110 | 15 | $59K |
| Donepezil Hcl Generic | 59 | 157 | 23 | $683 |
| Midodrine Hcl Generic | 48 | 107 | 14 | $3,665 |
| Mirtazapine Generic | 45 | 131 | 15 | $679 |
| Gabapentin Generic | 45 | 121 | 17 | $991 |
| Entacapone Generic | 40 | 107 | 14 | $6,295 |
Brand drugs: 209 claims; generic drugs: 3,061 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca S Tat $799 ($799 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $273.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $273 |
| SK Life Science, Inc. | 2 | $57.54 |
| Argenx US, Inc. ARGX | 3 | $54.93 |
| Medtronic, Inc. MDT | 2 | $41.62 |
| Ge Healthcare GEHC | 2 | $38.27 |
| TG Therapeutics, Inc. TGTX | 1 | $36.88 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $32.6 |
| Revance Therapeutics, Inc. | 1 | $31.59 |
| Genentech USA, Inc. ROG.SW | 1 | $28.05 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $27.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.